tagrisso

Introduction to tagrisso

Tagrisso is a medication primarily used in the form of tablets to treat non-small cell lung cancer (NSCLC) with specific genetic mutations. Tagrisso is often prescribed when other treatments have failed or are no longer effective.

Composition of tagrisso

Tagrisso contains the active ingredient Osimertinib, which is a tyrosine kinase inhibitor. This component works by blocking proteins that promote the growth and spread of cancer cells.

Uses of tagrisso

• Treatment of non-small cell lung cancer (NSCLC) with specific genetic mutations.
• Prescribed when other cancer treatments are ineffective.

Side effects of tagrisso

• Common side effects: Diarrhea, rash, and dry skin.
• Serious side effects: Potential problems in the lungs, heart, and eyes.

Precautions of tagrisso

Tagrisso may cause serious health issues, including lung, heart, and eye problems. It is not recommended during pregnancy due to potential harm to the baby. Always inform your doctor about any other medications you are taking to avoid interactions.

How to Take tagrisso

The usual starting dose of Tagrisso for adults is 80 mg once daily. It can be taken with or without food, and the tablet should be swallowed whole, not crushed or chewed. Follow your doctor's advice for the correct usage.

Conclusion of tagrisso

Tagrisso, containing the active ingredient Osimertinib, belongs to the therapeutic class of tyrosine kinase inhibitors. It is primarily used to treat non-small cell lung cancer with specific genetic mutations. Manufactured by AstraZeneca, Tagrisso is a key option when other treatments are ineffective. Always consult your healthcare provider for personalized advice and information about Tagrisso.